Trials / Completed
CompletedNCT02669862
A Study of A-101 Solution in Subjects With Common Warts.
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Solution in Subjects With Common Warts.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- Aclaris Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups.
Detailed description
This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups. During Visit 1, the Investigator will identify 1 eligible common wart on the trunk or extremities on each subject. The wart will be treated up to a maximum of 8 times at 1 week intervals during the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A-101 Solution 40 | |
| DRUG | A-101 Solution 45 | |
| DRUG | Vehicle Solution |
Timeline
- Start date
- 2015-12-21
- Primary completion
- 2016-09-16
- Completion
- 2016-09-16
- First posted
- 2016-02-01
- Last updated
- 2018-12-07
- Results posted
- 2018-12-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02669862. Inclusion in this directory is not an endorsement.